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Abstract
Background: MicroRNAs (miRs or miRNAs) regulate several biological processes in the cell. However, evidence for
miRNAs that control the differentiation program of specific neural cell types has been elusive. Recently, we have
shown that apoptosis-associated factors, such as p53 and caspases participate in the differentiation process of
mouse neural stem (NS) cells. To identify apoptosis-associated miRNAs that might play a role in neuronal
development, we performed global miRNA expression profiling experiments in NS cells. Next, we characterized the
expression of proapoptotic miRNAs, including miR-16, let-7a and miR-34a in distinct models of neural
differentiation, including mouse embryonic stem cells, PC12 and NT2N cells. In addition, the expression of
antiapoptotic miR-19a and 20a was also evaluated.
Results: The expression of miR-16, let-7a and miR-34a was consistently upregulated in neural differentiation
models. In contrast, expression of miR-19a and miR-20a was downregulated in mouse NS cell differentiation.
Importantly, differential expression of specific apoptosis-related miRNAs was not associated with increased cell
death. Overexpression of miR-34a increased the proportion of postmitotic neurons of mouse NS cells.
Conclusions: In conclusion, the identification of miR-16, let-7a and miR-34a, whose expression patterns are
conserved in mouse, rat and human neural differentiation, implicates these specific miRNAs in mammalian
neuronal development. The results provide new insights into the regulation of neuronal differentiation by
apoptosis-associated miRNAs.
Background
Adult neural stem (NS) cells and embryonic stem (ES)
cells are capable of differentiating into multiple cell
types of the adult nervous system [1,2]. This unique
property promises future medical applications, ranging
from regenerative medicine to drug screening. However,
the therapeutic use of NS cells and ES cells will require
the identification of cellular conditions that promote the
efficient commitment of these progenitors to particular
cell phenotypes.
Much progress has been made toward the elucidation
of specific differentiation signaling pathways. Surpris-
ingly, recent evidence suggests a functional role for
apoptosis-associated proteins such as p53 [3,4], caspases
[5] and Bcl-2 [6] in differentiation and development. In
addition, the recent discovery of microRNAs (miRs or
miRNAs) introduced a novel type of regulatory control
of gene expression during developmental processes [7,8].
miRNAs are a class of endogenous noncoding, highly
conserved RNAs of ~ 22 nucleotides in length [9]. They
regulate mRNA expression either by translation repres-
sion or cleavage of targeted mRNA [8]. In the past few
years, our understanding of miRNAs has expanded, and
a role for apoptosis-associated miRNAs in cell differen-
tiation is emerging.
Let-7a, a member of the let-7 family, is associated with
apoptosis by directly targeting caspase-3 [10]. Let-7 was
first identified in Caenorhabditis elegans and reported to
control the timing of fate specification during larval
development [11]. In addition, let-7a was also implicated
in neuronal differentiation [12,13]. However, the
mechanism by which let-7a regulates cell differentiation
is unknown.
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and their upregulation induces apoptosis and cell cycle
arrest [14-19]. In this regard, miR-34a has been shown
to regulate genes involved in cell cycle control and
apoptosis, including cyclin-dependent kinase 4 (CDK4),
CDK6, cyclin D1, E2F3 and SIRT [17,20,21]. A role for
miR-34a in megakaryocytic differentiation was recently
reported, where the miRNA regulates the expression of
MYB, and CDK4 and CDK6, thus promoting cell cycle
arrest [22]. Furthermore, miR-34a is involved in dendri-
tic cell differentiation [23], and is required for proper
differentiation of mouse ES cells by targeting Sirt1 [24].
miR-16 is implicated in induction of apoptosis by tar-
geting Bcl-2 [25], and is involved in cell cycle regulation
by targeting CDK6, cell division cycle protein 27
(CDC27), the caspase recruitment domain-containing
protein 10 (CARD10), cyclin D1 and cyclin E [26-28].
Nevertheless, an involvement of miR-16 in cell differen-
tiation is virtually unknown.
To gain further insight into the role of apoptosis-asso-
ciated factors during cell differentiation, we monitored
specific apoptosis-associated miRNAs during NS cell dif-
ferentiation. Our results showed that the differential
expression of miR-16, let-7a and miR-34a during mouse
NS cell differentiation was not associated with cell
death. In addition, upregulation of these miRNAs
observed in distinct models of neural differentiation
strongly suggests that apoptosis-associated miRNAs may
play a role in differentiation.
Methods
Cell Lines
Mouse NS Cells
Mouse NS cells containing a constitutively expressed
marker for green fluorescent protein (GFP) were used to
investigate the process of neural differentiation. Primary
cells were obtained from central nervous system tissue
of embryonic mice and cultured primarily as previously
described [29-31]. Mouse NS cells were maintained as
neurospheres in undifferentiation medium, serum-free,
1:1 mix of DMEM/F12 (Invitrogen Corp., Grand Island,
NY) with 1 × N-2 supplement (Invitrogen Corp.), 20
ng/ml epidermal growth factor (EGF) (R & D Systems
Inc., Minneapolis, MN), 20 ng/ml basic fibroblast
growth factor (bFGF) (PeproTech EC, London, UK), and
1% penicillin-streptomycin (Invitrogen Corp.), at 37°C in
humidified atmosphere of 5% CO2. Subculture occurred
at day 7 with mechanical dissociation of neurospheres.
The differentiation of mouse NS cells in vitro was
induced by culturing dissociated cells in differentiation
medium containing DMEM/F12 with 1 × N-2 supple-
ment, 100 ng/ml bFGF, 10% fetal bovine serum (FBS)
(Invitrogen Corp.), 500 nM all-trans retinoic acid
( S i g m aC h e m i c a lC o . ,S t .L o u i s ,M O ) ,5 0μMt a u r i n e
(Sigma Chemical Co.), 10 ng/ml transforming growth
factor-b2( T G F - b2) (R & D Systems Inc.) and 1% peni-
cillin-streptomycin in tissue culture plates pre-coated
with poly-D-lysine (Sigma Chemical Co.). The culture
medium was changed every 3 days. Differentiated cells
at 5 × 10
4 cells/ml were fixed at different time points,
and processed for immunostaining and evaluation of dif-
ferentiation. Cultures at 5 × 10
5 cells/ml were processed
for western blot and PCR analysis.
In parallel experiments, cell death was prevented by
adding tauroursodeoxycholic acid (TUDCA; Sigma Che-
mical Co.) to the culture medium. Briefly, cells with
3 days of differentiation were treated with 50 μMo f
TUDCA for 72 hours. At 6 days, cells were collected
and processed for evaluation of apoptosis and miRNA
expression.
miR-34a expression was modulated using 100 nM of
precursor control and pre-miR-34a (Applied Biosystems,
Foster City, CA). Mouse NS cells (2.5 × 10
5 cells/ml)
were transfected at 3 or 5 days of differentiation using
Lipofectamine 2000 (Invitrogen Corp) following manu-
facturer’s instructions.
Mouse ES Cells
The ES cell line 46C (Sox1-GFP) [32] was grown and
maintained as previously reported [33] and induced to
differentiate using a monolayer protocol. Specifically,
ES cells were plated in serum-free medium ESGRO
Complete Clonal Grade medium (Millipor Inc.) at high
density. After 24 hours, ES cells were gently dissociated
and plated onto 0.1% (v/v) gelatin-coated tissue culture
plastic at 1 × 10
4 cells/cm
2 in RHB-A media (StemCell
Science Inc.). For replating on day 4, cells were disso-
ciated and plated at 2 × 10
4 cells/cm
2 in laminin-coated
tissue culture plastic, using RHB-A medium supplemen-
ted with 5 ng/ml murine bFGF (PeproTech EC, London,
U K ) .C e l l sa td a y s4a n d8o fd i f f e r e n t i a t i o nw e r e
collected to evaluate expression levels of differentiation
markers and apoptosis-associated miRNAs. A positive
control for neural differentiation was also included at
day 8 using LY411575, a g-secretase inhibitor known to
inhibit the Notch pathway and thus enhance neuronal
differentiation. Cells were supplemented with either
0.01% DMSO (control) or 10 nM LY411575 (in 0.01%
DMSO) for 12 hours. LY411575-treated cells and
respective controls were photographed under an
inverted microscope Leica DMIL using a DC200 camera
(Leica Wetzlar, Germany)
PC12 Cells
Rat adrenal pheochromocytoma (PC12) cells were pro-
pagated in RPMI 1640 medium (Invitrogen Corp.) sup-
plemented with 10% horse serum (Invitrogen Corp.), 5%
FBS (Invitrogen Corp.) and appropriate antibiotics in an
humidified incubator maintained at 37°C with 5% CO2.
PC12 cells were differentiated in RPMI 1640 medium
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none, 5 or 50 ng/ml mouse nerve growth factor, (NGF
2.5S) (Chemicon, Temecula, CA) at 24 hours. Differen-
tiation medium was replaced and fresh NGF 2.5 D was
added every third day to differentiating cells. Cells were
collected at 1, 2, 4 and 7 days prior to differentiation to
evaluate expression levels of apoptosis-associated
miRNAs.
NT2N Cells
The human teratocarcinoma-derived Ntera2/D1 neuron-
like (NT2N) cells were obtained based on standard pro-
tocols with minor alterations [34,35]. Briefly, cells were
differentiated by treating adherent dividing cells with 10
μM all-trans retinoic acid (Sigma Chemical Co.) for up
to 3 weeks. Cells were collected at various time points
(0, 14 and 21 days); and for some a replate onto Matri-
gel coated culture dishes after 14 days of retinoic acid
was performed. Replated cells were incubated with mito-
sis inhibitors (1 μM cytosine D-arabinofuranoside, 10
μM fluorodeoxyuridine, 10 μM uridine) (Sigma Chemi-
cal Co.), in the absence of retinoic acid, and collected 7
days after treatment to evaluate expression levels of
apoptosis-associated miRNAs.
RNA isolation and semiquantitative reverse-transcriptase-
polymerase chain reaction (RT-PCR)
Total RNA was isolated from mouse NS cells, PC12 and
NT2N cells by TRIzol reagent (Invitrogen Corp.) accord-
ing to manufacturer’sp r o t o c o l .E Sc e l lR N A sw e r e
extracted using High Pure RNA Isolation kit (Roche
Diagnostics), with the inclusion of DNAse I treatment
according to manufacturer’s instructions. For semiquan-
titative RT-PCR, 0.5-1 μgo ft o t a lR N Af r o mN Sa n dE S
cells were reverse-transcribed using oligo(dT) (Integrated
DNA Technologies Inc., Coralville, IA) and SuperScript
II reverse transcriptase (Invitrogen Corp.). Specific oligo-
nucleotide primer pairs were incubated with cDNA tem-
plate for PCR amplification using the Expand High
Fidelity
PLUS PCR System from Roche Applied Science.
The following sequences were used as primers: Nestin
sense 5′-CTGGAACAGAGATTGGAAGGCCGCT-3′;
Nestin antisense 5′-GGATCCTGTGTCTTCAGAAA
GGCTGTCAC-3′; Mash1 sense 5′-AGATGAGCAAGGT
GGAGACG-3′; Mash1 antisense 5′-TGGAGTAGTTGG
GGGAGATG-3′;N g n 1s e n s e5 ′-ATGCCTGCCCC
TTTGGAGAC-3′;N g n 1a n t i s e n s e5 ′-TGCATGCGGTT
GCGCTCGC-3′;N g n 2s e n s e5 ′-ACCGCATGCA-
CAACCTAAAC-3′;N g n 2a n t i s e n s e5 ′-AGCGCCCA-
GATGTAATTGTG-3′;b - I I It u b u l i ns e n s e5 ′-AATGAG
GCCTCCTCTCACAA-3′; b-III tubulin antisense
5′-CTTGCTGATGAGCAGTGTGC-3′;G F A Ps e n s e
5′-CCAAACTGGCTGATGTCTACC-3′; and GFAP anti-
sense 5′-GCTTCATGTGCCTCCTGTCTA-3′,G A P D H
sense 5′-ATTCAACGGCACAGTCAAGG-3′;a n d
GAPDH antisense 5′ TGGATGCAGGGATGATGTTC-
3′. The ribosomal RNA subunit 28 S was used as control
when using mouse NS cells, while GAPDH was used as
control in mouse ES cells.
Preparation of labeled RNA and array hybridization
Microarray analysis was performed using a custom micro-
array platform, highly sensitive, allowing the profiling of
even weakly expressed miRNAs [36]. Briefly, a miRNA
probe set containing ~1140 oligonucleotides as probes,
complementary to Caenorhabditis elegans, Drosophila,
zebra fish, mouse, rat and human miRNAs was purchased
from Invitrogen. The set also included a number of inter-
nal and negative control probes. Oligonucleotides were
printed in quadruplicates on Corning GAPSII-coated
slides in the Microarray Facility at the University of
Minnesota. For RNA labeling, 25 μgo ft o t a lR N Aw a s
ligated to 0.5 μg of a synthetic linker, pCU-DY547 (Dhar-
macon, Lafayette, CO, USA). To control the hybridization
process, reference DNA oligonucleotides complementary
to a subset of mammalian miRNAs were combined and
labeled with a ULYSIS Alexa Fluor 647 Kit (Invitrogen
Corp.). Labeled RNAs and DNAs were then mixed and
hybridized to microarray slides [37]. Finally, slides were
scanned with a ScanArray 5000 machine (Perkin Elmer,
Waltham, MA, USA). Microarray images were processed
with Bluefuse software (BlueGnome, Cambridge, UK) to
quantify pixel intensities. Individual spots on the slides
were further inspected to exclude abnormal spots from
subsequent calculations.
Evaluation of miRNAs expression levels by quantitative
Real Time-PCR
Real-time PCR was performed in an Applied Biosystems
7300 Sequence Detection System (Applied Biosystems,
Foster City, CA). Ten nanograms of total RNA were
reverse transcribed using a TaqMan® MicroRNA Reverse
Transcription (RT) kit from Applied Biosystems. Each
RT reaction contained 1x stem-loop RT specific primer,
1 xr e a c t i o nb u f f e r ,0 . 2 5m Me a c ho fd N T P s ,3 . 3 3U / μl
Multiscribe RT enzyme and 0.25 U/μlR N a s ei n h i b i t o r .
The 15-μl reactions were incubated for 30 min at 16°C,
30 min at 42°C, and 5 min at 85°C and then held at
4°C. The PCR reaction was performed using a standard
TaqMan® PCR kit protocol (Applied Biosystems). Briefly,
following the RT step, 1.33 μl of the RT reaction were
combined with 1 μl of a TaqMAn MicroRNA Assay
(20x; forward primer, reverse primer and probe) and
17.67 μl of TaqMan® Universal PCR Master Mix, No
AmpErase® UNG in a 20 μl final volume. The reactions
were incubated at 95°C for 10 min, followed by 40
cycles of 95°C for 15 s and 60°C for 1 min; and were
r u ni nt r i p l i c a t e .m i R N Ae x p ression levels relative to
GAPDH (mouse NS cells, ES cells, and PC12) or
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method. GeNorm and Norm-Finder were used to iden-
tify the best stable combination of reference genes/single
gene for normalization in real-time PCR assays. Calibra-
tion was set using undifferentiated mouse NS cells,
mouse ES cells with 4 days of differentiation or
untreated with LY411575, PC12 with 1 day of differen-
tiation and undifferentiated NT2N cells or non-replated
NT2N cells. The n-fold change in miRNAs expression
was determined according to the method of 2
-ΔΔCT.
Immunoblotting
Steady-state levels of b-III tubulin, neuronal nuclei
(NeuN) and glial fibrillary acidic protein (GFAP) were
determined by Western blot. Total protein extracts of
mouse NS cells were prepared in lysis buffer, following
standard established protocols. Protein content was mea-
sured by the Bio-Rad protein assay kit according to the
manufacture’s specification, using bovine serum albumin
as standard. 50-80 μg of total protein extracts were sepa-
rated on 12% sodium dodecyl sulphate-polyacrylamide
electrophoresis gel and then subjected to immunoblots
using primary mouse monoclonal antibody reactive
to b-III tubulin (Tuj1, Covance, Princeton, NJ),
NeuN (MAB377, Chemicon International), and GFAP
(MAB360, Chemicon International). Blots were subse-
quently incubated with secondary antibodies conjugated
with horseradish peroxidase (Bio-Rad Laboratories, Her-
cules, CA, USA). Finally, membranes were processed for
protein detection using Immobilon (Millipore Corpora-
tion, Billerica, MA) or SuperSignal reagent (Pierce, Rock-
ford, IL). Ponceau S staining was used to assess equal gel
loading [38].
Immunocytochemistry
Mouse NS cells were fixed with paraformaldehyde (4%
w/v) in phosphate-buffered saline (PBS) and blocked for
1h o u ra tr o o mt e m p e r a t u r ei nP B Sc o n t a i n i n g0 . 1 %
Triton-X-100, 1% FBS, and 10% normal donkey serum
(Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA). Subsequently, cells were incubated with
either anti-b-III tubulin (rabbit, polyclonal; Chemicon
International) or anti-GFAP antibodies (mouse, mono-
clonal; Chemicon International) at a dilution of 1:1000
in blocking solution, overnight at 4°C. Cells were then
incubated with either anti-mouse or anti-rabbit IgG
conjugated to AMCA (Jackson ImmunoResearch
Laboratories, Inc.) and Alexa 594 (Molecular Probes-
Invitrogen), respectively, for 2 hour at room tempera-
ture. Samples were mounted using Fluoromount-G™
(Beckman Coulter, Inc.). Fluorescence microscopy
assessments were performed with a Zeizz AX10 micro-
scope (Carl Zeiss, Jena, Germany) equipped with a Leica
DFC490 camera (Leica Weitzlar, Germany). Living
undifferentiated cells were photographed under an
inverted microscope Leica DMIL with a DC200 camera
(Leica Weitzlar, Germany).
Assessment of apoptosis
Apoptosis was assessed by evaluating DNA fragmenta-
tion, nuclear morphology and phosphatidylserine
exposure.
Evaluation of DNA fragmentation by TUNEL assay.
Apoptosis-induced DNA fragmentation was determined
using the transferase mediated deoxyuridine triphosphate
(dUTP)-digoxigenin nick-end labeling (TUNEL) assay.
Cells were fixed with 4% (w/v) paraformaldehyde and
processed using an Apoptag in situ apoptosis detection
kit according to the manufacturer’s protocol (Chemicon
Int., Temecula, CA). The samples were examined using a
Leica DM 2500 bright-field microscope (Leica Weitzlar,
Germany).
Morphologic evaluation of apoptosis. Hoechst labeling of
mouse NS cells was used to detect apoptotic nuclei. In
brief, the medium was gently removed at the indicated
times with minimal detachment of the cells. Attached cells
were fixed with 4% (w/v) paraformaldehyde in PBS, pH
7.4, for 10 minutes at room temperature, incubated with
Hoechst dye 33258 (Sigma Chemical Co.) at 5 μg/ml in
PBS for 5 minutes, washed with PBS and mounted using
PBS:glycerol (3:1, v/v). Microscopy assessments were per-
formed with a Zeizz AX10 microscope (Carl Zeiss,
Jena, Germany) equipped with a Leica DFC490
camera (Leica Weitzlar, Germany). Normal nuclei showed
non-condensed chromatin dispersed over the entire
nucleus. Apoptotic nuclei were identified by condensed
chromatin, contiguous to the nuclear membrane, as well
as nuclear fragmentation of condensed chromatin.
Cytofluorometric analysis of apoptosis. Apoptotic cells
were quantified by cytofluorometric analysis using a
FACSCalibur (Becton Dickinson, Mountain View, CA)
as described previously [39]. Cells were stained with the
vital dye propidium iodide (PI; 5 μg/mL; Sigma, Stein-
heim, Germany) and concomitantly with Annexin-V-
APC (eBioscience, Inc.) according to manufacturer’s
instructions to determine the phosphatidylserine expo-
sure. Data were statistically evaluated using FlowJo soft-
ware (Tree Star, Inc, Ashland, OR).
Flow Cytometry
Cells were trypsinized (0.025% trypsin/EDTA; Invitrogen
Corp.) and harvested in Ca
2+-free and Mg
2+-free PBS
and 2% FBS. After washing, 0.5-1 × 10
6 cells were fixed
with paraformaldehyde (4% w/v) in PBS for 20 min on
wet ice, and blocked for 20 m i ni nP B S ,c o n t a i n i n g
0.25% saponin (Fluka, Biochemika, Switzerland) and 5%
normal donkey serum (Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA). Subsequently, cells
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International) at a dilution of 1:20 in PBS, containing
0.1% saponin and 5% normal donkey serum, for 30 min.
Cells were then incubated with anti-mouse antibody
conjugated to Cy5 (Jackson ImmunoResearch Labora-
tories, Inc.), for 20 min. Cells were analyzed using a
FACSCalibur (Becton Dickinson, Mountain View, CA).
Statistical Analysis
Results from different groups were compared using the
Student’s t test, or one-way ANOVA. Kruskal-Wallis or
the Mann-Whitney U tests were also used whenever the
assumptions of the parametric test were not satisfied.
Values of p < 0.05 were considered statistically signifi-
cant. All statistical analysis was performed with Graph-
Pad InStat software (GraphPad Software, Inc, San
Diego, CA).
Results
NS cells have both neurogenic and gliogenic potential
in vitro
It is known that both embryonic neural tissue and
certain regions of the adult vertebrate central nervous
system contain resident populations of progenitor/pre-
cursor stem cells [40]. NS cells can be isolated and
expanded as undifferentiated floating clusters called
neurospheres in the presence of bFGF and/or EGF [41].
In addition, NS cells have the ability to differentiate into
neurons, astrocytes and oligodendrocytes in a time con-
trolled fashion [42]. Thus, NS cells represent a powerful
in vitro model system for studying and elucidating the
molecular mechanisms that underlie neural differentia-
tion. Using mouse NS cells constitutively expressing
GFP (Figure 1A), we confirmed the differentiation
potential toward neuronal and glial fates by monitoring
the appearance of various cell-specific markers.
The proneural basic helix-loop-helix (bHLH) tran-
scription factor Neurogenin1 (Ngn1) was not expressed
in neurospheres, while Mash1 was readily detected
(Figure 1B). Following incubation in differentiation
medium, cells displayed a sharp increase in markers
for neurons and neural precursors. Ngn1 was readily
detected at 6 hours and tended to decrease during cell
differentiation. Mash1 was slightly increased but not
significantly modulated. Upregulation of proneural
bHLH transcription factors was associated with a sub-
sequent increase in b-III tubulin at both the mRNA
and protein levels, indicating that neurogenesis is
induced early after cell incubation in differentiation
medium. At the protein level, b-III tubulin expression
peaked at 1 day of differentiation and gradually
decreased thereafter (Figure 1C). These results sug-
gested that the neurogenic potential of mouse NS cells
rapidly decreased with differentiation.
In cell culture, there is an inverse relationship between
Ngn expression and the propensity of the neural
progenitors to undergo differentiation into astrocytes,
suggesting that proneural bHLH factors might act to
suppress the formation of astrocytes [43]. In agreement
with these observations, the glial marker GFAP was only
detected at day 3, in association with decreased levels of
Ngn1 and concomitant with a reduction in the number
of neurons. Importantly, analysis of NeuN protein
expression revealed postmitotic neurons after 6 days of
differentiation. Finally, analysis by immunocytochemistry
using b-III tubulin and GFAP markers further
confirmed the decreased neurogenic potential of mouse
NS cells throughout differentiation, and the generation
of glial cells after the peak of neuronal production
(Figure 1D).
Apoptosis-associate miRNAs are differentially modulated
during mouse neural stem cell differentiation
miRNAs are thought to play a role in cancer pathogen-
esis. In fact, a specific subset of miRNAs is upregulated
in most cancer profiles, and are, therefore, considered to
be antiapoptotic miRNAs [44]. The best characterized of
that subgroup are miR-21, miR-222, miR-221, miR-17-
92 cluster, miR-106 and miR-155. In contrast, proapop-
totic miRNAs are usually downregulated in cancer, and
include miR-15, miR-16, the let-7 family and members
of the miR-34 family. Importantly, we have recently
shown that apoptosis-associated factors temporally mod-
ulate mouse NS cell differentiation [45]. As miRNAs
have recently been implicated in neural differentiation
[46], we sought to investigate whether apoptosis-specific
miRNAs are particularly relevant during mouse NS cell
differentiation.
Global miRNA expression profiling studies revealed
differential expression patterns of apoptosis-related miR-
NAs throughout mouse NS cell differentiation (Tables 1
and 2). In general, let-7 family members were upregu-
lated at 3 days, and decreased at 8 days of differentia-
tion. Interestingly, and similar to miR-34a/b/c, miR-16
was upregulated at both 3 and 8 days of neural differen-
tiation. In contrast, antiapoptotic miRNAs were in gen-
eral downregulated at 8 days. Further analysis of the
differentially expressed miRNAs involved clustering ana-
lysis into different groups, according to variations in the
apoptosis-associated miRNAs expression (Additional file
1). Less differentiated cells (1 and 3 days) were grouped
separately from those that were more differentiated
(8 days). Importantly, similar grouping was not achieved
in clustering analysis using all detected miRNAs.
Based on a possible link between miR-16, let-7a and
miR-34a with known apoptotic molecules that have
already been associated with differentiation, we decided
to validate microarray data for the three proapoptotic
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quantitative real time-PCR (Figure 2). Antiapoptotic
miR-19a and miR-20a, two miR-17-92 cluster members
were also investigated. Proapoptotic miRNAs were con-
firmed to be upregulated during mouse NS cell differen-
tiation. Notably, miR-16 expression levels were
significantly increased from 12 hours to 3 days of differ-
entiation, when compared with undifferentiated cells
(p < 0.05) (Figure 2). Still, its expression levels remained
elevated throughout differentiation. Similarly, let-7a was
significantly upregulated following induction of differen-
tiation, increasing almost 4- and 3-fold at 6 and 12
hours, respectively (p < 0.05). After returning to basal
levels at day 2, let-7a expression was again significantly
upregulated at day 3 and 6, by 2.6- and 3.5-fold, respec-
tively (p < 0.05), slightly decreasing at day 8 (p < 0.01).
miR-34a, in turn, was modulated primarily beyond
the third day of differentiation. After a 3-fold increase
at 3 days (p < 0.01), miR-34a was further upregulated
at day 6 by ~ 11-fold (p < 0.001), comparing with
Figure 1 Mouse NS cells have both neurogenic and gliogenic potential in vitro. Mouse NS cells were expanded in the presence of EGF
and bFGF, and induced to differentiate as described in Materials and Methods. Cells were harvested for total RNA and protein extraction, or fixed
at different time points and processed for immunostaining analysis. Neuronal differentiation was readily detected after incubation in
differentiation medium, while glial production was only observed from day 3. A) Mouse NS cells constitutively expressing GFP were grown in
suspension as neurospheres that increased in number and size with cell proliferation (phase contrast and GFP fluorescence images). B) Semi-
quantitative RT-PCR analysis for selected markers of lineage commitment at successive time-points of mouse NS cell differentiation.
Neurospheres (undifferentiated NS cells) collected before platting in differentiation medium were considered 0 time differentiation. Data was
normalized to 28 S. C) Representative immunoblots showing protein expression of neuronal (b-III tubulin and NeuN) and glial (GFAP) markers
during mouse NS cell differentiation. Ponceau S was used as loading control. D) Mouse NS cells labeled with anti-b-III tubulin and anti-GFAP
antibodies, to visualize neurons and glial cells, respectively. Representative immunostaining images were from at least 3 independent
experiments. Scale bar: 50 μm. Ngn1, neurogenin1; GFAP, glial fibrillary acidic protein; NeuN, neuronal nuclei; h, hours; d, days.
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decrease in miR-34a expression occurred from day 6 to
day 8.
The synchronous induction of proapoptotic miRNAs
s u g g e s t e dt h a tt h e ym a yp l a yar o l ed u r i n gm o u s eN S
cell differentiation. In contrast, antiapoptotic miR-20a
was mainly downregulated throughout neural differen-
tiation. In fact, its expression levels were ~ 2-fold down-
r e g u l a t e df r o m6d a y sa n db e y o n d( p <0 . 0 0 1 ) ,
compared to undifferentiated cells. Curiously, miR-19a
expression was mostly increased during the first 3 days
of differentiation, gradually decreasing toward control
levels. The onset of miR-19a expression correlates with
induction of proliferation during the first 3 days of dif-
ferentiation (data not shown).
Expression of apoptosis-related miRNAs is not associated
with increased cell death during mouse NS cell
differentiation
To exclude the possibility that expression of proapopto-
t i cm i R N A si sa s s o c i a t e dw i t h increased cell death, we
evaluated cellular apoptosis during mouse NS cell
differentiation using Hoechst staining, TUNEL assay and
cytofluorometric analysis. Undifferentiated cells exhib-
ited major apoptosis-associated alterations, including
chromatin condensation and nuclear fragmentation
(Figure 3A, Hoechst), DNA fragmentation (Figure 3A,
TUNEL), exposure of phosphatidylserine on the outer
leaflet of the plasma membrane (detected with annexin
V-APC conjugates) (Figure 3B and 3C), as well as mem-
brane permeabilization, as indicated by the staining with
the vital dye PI. Importantly, induction of cell differen-
tiation resulted in minor alterations in nuclear morphol-
ogy, while DNA fragmentation was slightly detected
during the first two days of differentiation. In addition,
phosphatidylserine exposure was only slightly increased
from day 3 to day 6, but always less than 6% during
differentiation. Furthermore, no significant loss of cell
viability was observed. Taken together, our results indi-
cated that differentiation of mouse NSC was not asso-
ciated with a significant increase of cell death.
All three proapoptotic miRNAs increased from day 3
to day 6 of differentiation. In addition, a concomitant
increase in cell death was also observed. Thus, to
Figure 2 Apoptosis-associated miRNAs are modulated during mouse NS cell differentiation. Expression of specific proapoptotic (miR-16,
let-7a and miR-34a) and antiapoptotic miRNAs (miR-20a and miR-19a) were analyzed by quantitative Real Time-PCR from 10 ng of total RNA
using specific Taqman primers and GAPDH for normalization. *p < 0.05, †p < 0.01 and §p < 0.001 compared to day 0 (undifferentiated cells).
Expression levels were calculated by the ΔΔCt method using undifferentiated cells as calibrator. Data represent mean ± SEM of four independent
experiments.
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Page 7 of 15exclude the role of these specific miRNAs in apoptosis,
we inhibited apoptosis at 6 days and reevaluated
changes on miRNA expression (Figure 4). Incubation
with the antiapoptotic TUDCA for 72 hours, reduced
Annexin+/PI- cells from 6.4% to 5.3% (Figure 4A and
4B). In addition, loss of cell viability (Annexin+/PI+
cells) was significantly reduced from 14.2% to 10.6%
(p < 0.05). More importantly, the decrease in cell death
after TUDCA treatment did not decrease the expression
of proapoptotic miRNAs (Figure 4C). These results
strongly suggested that modulation of miR-16, let-7a
and miR-34a was most likely due to cell differentiation
rather than cell death.
Apoptosis-associated miRNAs are upregulated in different
models of neural differentiation
To further validate the role of the proapoptotic miR-
NAs, miR-16, let-7a and miR-34a in neural cell differen-
tiation, we investigated whether they were upregulated
in other neural differentiation models, including mouse
ES cells, PC12 and NT2N cell lines. The generation of
n e u r o n sf r o mE Sc e l l sh a sr e p roducibly been character-
ized in vitro [32,33]. Neural progenitors derived from ES
cells organize themselves into rosette-like structures that
can subsequently differentiate into neurons, astrocytes
and oligodendrocytes. Using t h es a m ed i f f e r e n t i a t i o n
protocol, neurogenesis was evidenced by increased Ngn2
and b-III tubulin mRNA expression levels at 8 days of
differentiation (Figure 5A). The neural progenitor mar-
ker Nestin was also increased, suggesting a concomitant
increase in neural progenitors. In fact, at this stage of
differentiation, expression levels of miR-16, let-7a and
miR-34a were increased when compared with day 4
(Figure 5B). The inhibition of Notch pathway at 8 days
of differentiation by LY411575 treatment resulted in
increased neuronal production. In fact, neuronal mar-
kers, particularly Ngn2, were increased, and morphologi-
cal evaluation was consistent with the presence of
differentiated cells (Figure 5A and 5C). Notably,
LY411575-induced neurogenesis resulted in a significant
increased of miR-16 and miR-34a, by 3- and 2-fold (Fig-
ure 5B), respectively (p < 0.05), supporting the potential
involvement of both miRNAs in neuronal differentiation.
Glial differentiation was not detected in the time points
analyzed (data not shown).
It has been previously described that differentiation of
PC12 cells can be induced by NGF [47]. Cell differentia-
tion increases during the first 7 days of treatment with
NGF, as measured by neuronal outgrowth and mRNA
levels of specific neurofilaments [48]. Moreover, this cor-
relation decreases with lower NGF concentrations. Our
results demonstrated that treatment of PC12 cells with
50 ng/ml of NGF markedly induced miR-16 expression
at 2 and 4 days, compared with NGF-untreated cells
Figure 3 Differentiation of mouse NS cells is not associated
with increased cell death. Mouse NS cells at different days of
differentiation were fixed and processed for either morphological
evaluation of apoptosis or TUNEL assay, or were stained with
Annexin-V-APC/PI. A) Evaluation of apoptosis by Hoechst staining
and TUNEL assay. Representative images from at least three
independent experiments. Arrows indicate apoptotic cells. B)
Representative FACS diagrams depicting the percentages of either
dying (Annexin+/PI-) or dead (Annexin+/PI+) cells. C) Quantitation
of the data depicted in FACS diagrams. Results are mean ± SEM.
This experiment was repeated at least three times, yielding
comparable results. Scale bar: 10 μm. d, days.
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Page 8 of 15(Figure 6A). Indeed, miR-16 expression increased by 1.8-
(p < 0.01) and 1.4-fold (p < 0.05) at 2 and 4 days, respec-
tively. Nevertheless, no difference in miR-16 expression
levels was detected at 7 days, under different NGF treat-
ments. Interestingly, 24 hours after treatment with 50 ng/
ml of NGF, let-7a expression was ~ 5-fold upregulated in
differentiated PC12 cells (p < 0.05). Under identical con-
ditions, let-7a expression remained elevated throughout
t h et i m ec o u r s e( p < 0.05). Notably, miR-34a expression
was also gradually upregulated after NGF treatment.
Although to a lesser extent, similar results were obtained
for all three miRNAs under suboptimal NGF 5 ng/ml
concentrations. None of the selected miRs were modu-
lated in NGF-untreated cells.
Human teratocarcinoma NT2 cells generate postmito-
tic neurons (NT2N) in response to retinoic acid and
mitotic inhibitors [49]. Retinoic acid treatment of NT2
cells induced neuronal differentiation as evidenced by
the expression of the neuronal marker NeuroD at 14
and 21 days, as well as increased expression of b-III
tubulin (data not shown). In NT2N, miR-16 expression
was increased by 3.6-fold at day 14 (p < 0.001) and
almost 4-fold at day 21 (p < 0.05) of differentiation
(Figure 6B). Similarly, let-7a was highly upregulated,
particularly at 21 days of retinoic acid treatment (p <
0.05). In contrast, miR-34a was not modulated during
cell differentiation. Replated cells showed increased
differentiation, as evidenced by the increase in b-III
Figure 4 Inhibition of apoptosis by TUDCA was not associated with a decrease in proapoptotic miRNAs expression.M o u s eN Sc e l l s
with 3 days of differentiation were either untreated or treated with 50 μM of TUDCA for 72 hours. Collected cells were stained with Annexin-V-
APC/PI to evaluate cell death, or processed for total RNA extraction and miRNAs expression evaluation by quantitative Real Time-PCR. A)
Representative Annexin V-APC/PI stainings showing decreased cell death after TUDCA incubation. B) Quantitation of either dying (Annexin+/PI-)
or dead (Annexin+/PI+) cells depicted in FACS diagrams. Results are mean ± SEM of triplicates. C) Expression of proapoptotic miRNAs at 3 and 6
days, with or without TUDCA treatment. miR-16, let-7a and miR-34a expression were evaluated from 10 ng of total RNA, using specific primers
for each miRNA, and GAPDH for normalization. Expression levels were calculated by the ΔΔCt method using differentiated cells at 3 days as
calibrator. Data represent mean ± SEM of three independent experiments. *p < 0.05 compared to respective nontreated cells at 6 days.
Aranha et al. BMC Genomics 2010, 11:514
http://www.biomedcentral.com/1471-2164/11/514
Page 9 of 15Figure 5 miR-16, let-7a and miR-34a are increased during mouse ES cell differentiation. Mouse ES cells (Sox1-GFP 46C) were differentiated
using an adherent monolayer protocol. Cells at 4 and 8 days were collected for total RNA extraction and subsequently processed for evaluation
of specific differentiation markers, as well as proapoptotic miRNA expression by quantitative Real Time-PCR. A positive control for neural
differentiation was also performed at day 8 by treating cells with either 10 nM LY411575 or 0.01%DMSO (control) for 12 hours. A) Semi-
quantitative RT-PCR analysis for selected markers of lineage commitment in day 4 and 8, as well as in LY411575-treated and untreated cells. B)
Representative bright-field, phase contrast images showing increased neuronal differentiation after LY411575 incubation compared with control
(DMSO-treated) cells. C) Expression of miR-16, Let-7a and miR-34a at 4 and 8 days of ES cell differentiation and in control (DMSO-treated) and
LY411575-treated rosette cultures at 8 days. miRNAs expression were evaluated from 10 ng of total RNA, using specific primers for each miRNA,
and GAPDH for normalization. Expression levels were calculated by the ΔΔCt method using either differentiated cells at 4 days or LY411575-
untreated cells as calibrator. Data represent mean ± SEM of three independent experiments. *p < 0.05 compared to respective nontreated cells.
Scale bar: 50 μm. d, days.
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Page 10 of 15tubulin-positive cells and detection of NeuN-positive
cells (data not shown). Surprisingly, increased differen-
tiation after replating was associated with a significant
decrease in both miR-16 and let-7a expression by ~ 2
(p <0 . 0 5 )a n d5 - f o l d( p < 0.001), while miR-34a
increased by 4.5-fold (p <0 . 0 5 ) ,c o m p a r e dw i t hn o n -
replated cells.
miR-34a was the most significantly upregulated
miRNA during mouse NS cell differentiation (~ 11-fold
between days 3 and 6; p <0 . 0 0 1 )c o m p a r e dt oo t h e r
apoptosis-associated miRNAs. Because miR-34a upregu-
lation coincides with the onset of postmitotic neurons,
we investigated the effect of miR-34a upregulation in
this population by evaluating NeuN expression. We
used flow cytometry to determine the proportion of the
postmitotic neuronal population (Additional file 2). The
proportion of NeuN-positive cells was significantly
increased when compared to cells transfected with unre-
lated RNA duplexes (Figure 7A). In fact, NeuN-positive
cells increased from 29.7 to 38.9% 24 h after
Figure 6 Differentiation of PC12 and NT2N cells were associated with modulated levels of miR-16, let-7a and miR-34a expression.
PC12 cells were differentiated upon NGF treatment at 1 day with either 5 or 50 ng/ml. NGF-untreated cells were also prepared. Cells were
collected at 1, 2 4 and 7 days. NT2N cells were induced to differentiate with 10 μM all-trans retinoic acid and collected at 0, 14 and 21 days. In
parallel experiments, cells were replated at 14 days in Matrigel, deprived of retinoic acid and incubated with mitotic inhibitors and further
cultured for 7 days. Control cells were maintained in initial retinoic acid treatment. Both PC12 and NT2N-collected cells were processed for total
RNA extraction and evaluation of miRNAs expression levels using quantitative Real Time-PCR. A and B) miR-16, let-7a and miR-34a expression
during PC12 and NT2N differentiation, respectively. miRNAs expression were evaluated from 10 ng of total RNA, using specific primers for each
miRNA. GAPDH and RNU6B were used for normalization in PC12 and NT2N cells, respectively. Expression levels were calculated by the ΔΔCt
method. NGF-untreated cells at 1 day was used as calibrator in PC12 cells, while undifferentiated (day 0) or unreplated cells were used as
calibrator in NT2N cells. Data represent mean ± SEM of three independent experiments. A) *p < 0.05 and
†p < 0.01 compared to 1 day. miR-16
and let-7a expressions in cells treated with 5 and 50 ng/ml NGF were also significantly different from NGF untreated cells at day 4 (p < 0.05) and
d a y2( p < 0.01), respectively. B) *p < 0.05 and
§p < 0.001 compared to day 0;
†p < 0.05 and
‡p < 0.001 compared to unreplated cells. d, days.
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Page 11 of 15transfection. This increase was further enhanced from
27.3 to 66.6% at 72 h post-transfection. In addition,
these results were confirmed by Western blot analysis
(Figure 7B). No changes were detected in the proportion
of astrocytes in the pre-miR-34a transfected cells (data
not shown). These results indicated that miR-34a contri-
butes to neuronal differentiation in mouse NS cells.
Discussion
Differentiation of NS and ES cells in vitro has attracted
wide interest as an experimental system for investigating
specific molecular pathways of cell development. Here,
we have demonstrated neuronal and glial conversion of
mouse NS cells. In this model, the neuronal population
is formed mainly during the first 2 days, as indicated by
the upregulation of b-III tubulin. Nevertheless, commit-
ment to mature neurons was confirmed by the expres-
sion of NeuN at 6 days, which indicates the presence of
immature postmitotic neurons. Astrocytic population
peaked at 6 days, and this was maintained throughout
differentiation.
Functional studies of apoptosis-associated miRNAs
have focused intensely on cancer research. However, our
results demonstrate that specific miRNAs regulating
pro-and antiapoptotic genes may also participate in dif-
ferentiation processes. The involvement of miR-16 in
cell differentiation has not been previously reported.
Indeed, miR-16 expression was markedly increased
throughout mouse, rat and human neural differentiation.
Nevertheless, the onset of miR-16 expression during
mouse NS cell differentiation was not associated with
the appearance of any specific cell type. miR-16 was
shown to be implicated in cell cycle regulation, as well
as apoptosis induction by targeting Bcl-2 [25-28]. Apop-
t o s i si sn o tm a r k e d l yr e g u l a t e dd u r i n gm o u s eN Sc e l l
differentiation, and Bcl-2 expression is increased (data
not shown). Therefore, a possible role for miR-16 in the
context of differentiation may be associated with cell
cycle control in downregulating the proliferation poten-
tial of differentiating cells. During differentiation of
neural precursors, a tightly coordinated regulation of
cell cycle exit is crucial for the generation of appropriate
number of neurons and proper wiring of neuronal
circuits [50]. Nevertheless, here-to-fore unrecognized
miR-16 targets may exert distinct, yet crucial functions
during cell differentiation.
The let-7 family consists of eleven very closely related
genes [51]. They are highly conserved in animals from
worms to humans, and their expression increases after
differentiation and maturation of tissues [52]. In addi-
tion to regulating apoptosis by targeting caspase-3 [10],
it was also demonstrated that let-7 family members
Figure 7 miR-34a overexpression increases the ratio of
postmitotic neurons in mouse NS cells. Mouse NS cells were
transfected using 100 nM of either control or pre-miR-34a, and
collected 24 and 72 h after transfection. Collected cells were labeled
for NeuN detection by flow cytometry, or processed for total
protein extraction and NeuN expression evaluation by Westen blot.
A) Percentage of NeuN positive cells in negative control and pre-
miR-34a-transfected cells, 24 and 72 h after transfection. In
independent repetitions of these experiments, similar increases in
the relative number of NeuN-positive cells were observed in
cultures overexpressing miR-34a when compared to control pre-
miR-transfected cells. B) Representative blot showing increased
NeuN expression in pre-miR-34a transfected cells.
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Page 12 of 15regulate RAS and HMGA2 oncogene through the 3′UTR
[53-55]. In the present study, let-7a expression was
shown to be cyclic during mouse NS cells differentia-
tion, and corresponded to the onset of neurogenesis and
gliogenesis. This suggests that let-7a expression is asso-
ciated with a general mechanism of differentiation
rather than differentiation of specific cell types. Our
results are supported by the previous report showing
that let-7a is a critical regulator of neuronal differentia-
tion [12,13]. In fact, increased let-7a expression during
ES cells, PC12 and NT2N differentiation also under-
scores the important role of let-7a during general differ-
entiation. Additional studies are warranted to evaluate
the mechanism(s) by which let-7a regulates cell differen-
tiation. Importantly, although highly modulated during
cell differentiation, both let-7a and miR-16 were signifi-
cantly expressed in neurospheres (data not shown).
Therefore, it is possible that additional mechanisms
exist to antagonize let-7a and miR-16 expression during
NS cell differentiation.
A specific role for miR-34a during neuronal differen-
tiation has not been reported. Interestingly, herein we
showed a significant upregulation of miR-34a during
mouse NS cell differentiation, and this paralleled the
appearance of postmitotic neurons. In addition, in vitro
transient overexpression of miR-34a increased the pro-
portion of NeuN-positive cells. Given that miR-34a has
been shown to regulate genes involved in cell cycle
arrest, it is possible that miR-34a upregulation is related
to cell cycle exit and the subsequent appearance of
immature postmitotic neurons. In fact, miR-34a upregu-
lation in ES cells after LY treatment, as well as in NT2N
cells after incubation with the mitosis inhibitor, supports
this hypothesis. In addition, it has been previously
shown that miR-34a can suppress cell-cycle genes and
induce neural phenotype in neuroblastoma tumors [56].
Importantly, it has been previously reported that miR-
34a overexpression had no effect on cell cycle arrest and
survival/apoptosis of astrocytes [57,58]. However, addi-
tional studies are required to confirm the influence of
miR-34a in neurogenesis and evaluate whether it med-
iates p53 effects on cell differentiation. In fact, several
potential miR-34a targets might be involved in the tran-
sition towards postmitotic neurons. It was previously
demonstrated that miR-34a targets Sirt1 and is regulated
by p53, which in turn, is activated by Sirt1 suppression
[59]. In addition, miR-34a may also regulate the differ-
entiation process by influencing Notch signaling path-
way [57,60]. In contrast to let-7a and miR-16, miR-34a
was barely detected in undifferentiated cells, supporting
its specific involvement in cell differentiation.
miR-19a and miR-20a are members of the miR-17-92
cluster [61], which consists of seven mature miRNAs,
previously linked to tumorigenesis. Recently, additional
functions have been assigned to this cluster, particularly
to miR-20a and miR-19a. Specifically, miR-20a was
shown to control monocyte differentiation [62]. In fact,
transfection of hematopoietic progenitors with miR-20a
increased the proliferation of monocytes and blocked
differentiation, whereas inhibition of miR-20a caused a
decrease in proliferation and more rapid differentiation
and maturation. Our results, showing that miR-20a
decreases during mouse NS cell differentiation, are in
agreement with this previous report.
Only limited information is available regarding the
physiological role of miR-19a. It has been demonstrated
that it acts as a positive regulator of antiapoptotic Stat3/
IL-6 receptor signaling by directly suppressing SOCS-1,
thereby facilitating malignant growth of multiple mye-
loma [63]. Further, miR-19 appears to affect the level of
proapoptotic protein Bim, thereby preventing apoptosis
and promoting cell survival. The possible role of miR-
19a on cell survival, may explain why this miRNA was
upregulated at early stages after the induction of mouse
NS cell differentiation. However, additional studies are
required to determine the specific role of both miR-20a
and miR-19a during cell differentiation, and also evalu-
ate if their expression is restricted to a specific cell type.
Conclusions
In conclusion, our results demonstrate that apoptosis-
associated miRNAs are differentially expressed during
neural differentiation, in the absence of cell death, and
identify miR-16, let-7a and miR-34a as important
players.
Additional material
Additional file 1: Clustering analysis. Clustering analysis of
differentiated mouse NS cells based on apoptosis-associated miRNA
expression levels at 1, 3 and 8 days.
Additional file 2: Flow cytometry analysis. Forward scatter/side scatter
(FSC/SSC) distribution of mouse NS cells. Unstained controls, in which
incubation with primary antibody was avoided, were performed to
determine the limit at which fluorescence intensity can be considered
specific.
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